BACKGROUND
Transcatheter aortic valve implantation (TAVI) is an established therapy for severe aortic stenosis. Among patients with left ventricular (LV) systolic dysfunction, recovery of LV function after TAVI is heterogeneous, and reliable tools for pre-procedural risk stratification and patient counseling remain lim...
Yuki Hida, Teruhiko Imamura, H. Ueno et al.· Catheterization and cardiova...· 0 citations
Introduction: Esophageal schwannomas are rare, benign tumors arising from Schwann cells in the esophageal wall. Giant forms are particularly rare and can resemble mediastinal tumors, making preoperative diagnosis difficult. Case presentation: Herein, we present the case of a 55-year-old man with hypertension, obesity,...
Masaaki Saito, K. Ishizu, Kosuke Ichida et al.· International journal of sur...· 0 citations
BACKGROUND
Bioprosthetic valve failure (BVF) is a key clinical endpoint for evaluating valve durability after transcatheter aortic valve implantation (TAVI). However, in populations with substantial competing mortality or heterogeneous follow-up durations, the estimated incidence of BVF may vary according to evaluation...
H. Hioki, M. Yamamoto, T. Shimura et al.· International Journal of Car...· 0 citations
Background Patients with extremely small aortic annuli are at increased risk of residual gradients and prosthesis-patient mismatch (PPM) after transcatheter aortic valve replacement (TAVR). Comparative data on contemporary valve platforms in this subset remain limited. Objectives The authors aimed to compare early clin...
Shinichi Shirai, H. Hioki, M. Yamamoto et al.· JACC: Asia· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.